Tsujitani S, Nakashima M, Watanabe T, Kaibara N, Koprowski H, Steplewski Z
Wistar Institute, Philadelphia, Pennsylvania 19104-4268, USA.
Anticancer Res. 1995 May-Jun;15(3):655-60.
We studied effects of varied cytokine combinations on allogeneic cytotoxic T lymphocyte (CTL) generation in a mixed lymphocyte-tumor cell culture. Sensitized with allogeneic melanoma cell line (MM-8.1 or MM-28), peripheral blood mononuclear cells (PBMC) were cultured in medium containing various combinations of cytokines that included human recombinant interleukin-2 (rIL-2) alone (MB-2), rIL-2 and rIL-4 (MB-2,4) and rIL-1, rIL-2, rIL-4 and rIL-6 (MB-1,2,4,6). Lymphocytes proliferated for more than 50 days and manifested stimulating cell-specific cytotoxicities in 1 of 5 cultures with MB-2, in 4 of 5 with MB-2,4 and in 5 of 5 with MB-1,2,4,6. Lymphocytes grew up to 10(6) fold in culture with MB-2,4 or MB-1,2,4,6 at day 90-100. Stimulating cell MM-8.1 (HLAABC+,DR-) induced CD3+, CD8+, CD56- CTLs and MM-28 (HLA-ABC+, DR+) mainly generated CD3+, CD4+, CD56- CTLs. Monoclonal antibodies against HLA-ABC and HLA-DR molecules suppressed the stimulating cell-specific cytolytic activity of CD8+ and CD4+ CTLs, respectively. These data indicate that combination of rIL-1, rIL-2, rIL-4 and rIL-6 offer an efficient system to generate allogeneic, tumor-specific CTLs from PBMCs and that HLA molecules expressed on stimulating cells play an important role in CTL generation.
我们研究了不同细胞因子组合对混合淋巴细胞 - 肿瘤细胞培养中同种异体细胞毒性T淋巴细胞(CTL)生成的影响。用同种异体黑色素瘤细胞系(MM - 8.1或MM - 28)致敏后,外周血单个核细胞(PBMC)在含有各种细胞因子组合的培养基中培养,这些组合包括单独的人重组白细胞介素 - 2(rIL - 2)(MB - 2)、rIL - 2和rIL - 4(MB - 2,4)以及rIL - 1、rIL - 2、rIL - 4和rIL - 6(MB - 1,2,4,6)。淋巴细胞增殖超过50天,在使用MB - 2的5个培养物中有1个表现出刺激细胞特异性细胞毒性,在使用MB - 2,4的5个培养物中有4个表现出刺激细胞特异性细胞毒性,在使用MB - 1,2,4,6的5个培养物中均表现出刺激细胞特异性细胞毒性。在第90 - 100天,使用MB - 2,4或MB - 1,2,4,6培养时,淋巴细胞增殖至原来的10⁶倍。刺激细胞MM - 8.1(HLA - ABC⁺,DR⁻)诱导产生CD3⁺、CD8⁺、CD56⁻ CTL,而MM - 28(HLA - ABC⁺,DR⁺)主要产生CD3⁺、CD4⁺、CD56⁻ CTL。抗HLA - ABC和HLA - DR分子的单克隆抗体分别抑制了CD8⁺和CD4⁺ CTL的刺激细胞特异性溶细胞活性。这些数据表明,rIL - 1、rIL - 2、rIL - 4和rIL - 6的组合提供了一个从PBMC生成同种异体、肿瘤特异性CTL的有效系统,并且刺激细胞上表达的HLA分子在CTL生成中起重要作用。